Susquehanna Fundamental Investments, LLC Electro Core, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.18 $74,073 - $93,985	-79,649 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$1.19 - $2.06 $40,364 - $69,875	-33,920 Reduced 29.87%	79,649 $95,000
Q1 2021 May 17, 2021	BUY	$1.62 - $3.05 $114,210 - $215,025	70,500 Added 163.69%	113,569 $234,000
Q4 2020 Feb 16, 2021	SELL	$1.44 - $1.98 $23,788 - $32,709	-16,520 Reduced 27.72%	43,069 $67,000
Q3 2020 Nov 16, 2020	BUY	$0.8 - $2.33 $47,671 - $138,842	59,589 New	59,589 $103,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $798M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.